Evidence map›Paper›PMID 37174130›Full record

ArticleCancers2023

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study.

Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Mottaghy, Agnieszka Morgenroth

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ramya Ambur SankaranarayananDepartment of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.
Jennifer PeilDepartment of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.
Andreas T J VoggDepartment of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0003-0696-3978
Carsten BolmInstitute of Organic Chemistry, RWTH Aachen University, 52056 Aachen, Germany.ORCID 0000-0001-9415-9917
Steven TerhorstInstitute of Organic Chemistry, RWTH Aachen University, 52056 Aachen, Germany.
Arno ClassenInstitute of Organic Chemistry, RWTH Aachen University, 52056 Aachen, Germany.
Matthias BauwensDepartment of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.
Jochen MaurerDepartment of Gynecology and Obstetrics, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0003-3962-3128
Felix MottaghyDepartment of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-7212-6521
Agnieszka MorgenrothDepartment of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-5712-6881

Funding

Deutsche Forschungsgemeinschaft 331065168
6 · The paper itself

Abstract

The authors wish to replace the 'Author Contributions' statement and the affiliation for Jochen Maurer of this article [...].

Identifiers

PMID37174130
PMCPMC10177469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.